Blinded by the light: molecular imaging in pancreatic adenocarcinoma.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 21106729.
- Also identified by DOI 10.1158/1078-0432.CCR-10-2825.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The early detection and optimal perisurgical management of pancreatic adenocarcinoma are paramount goals in our quest to increase cure rates in this lethal malignancy. Molecular imaging techniques may be the conduit through which new genomic and proteomic discoveries about this disease are brought to the clinic.
Medical subject headings
- Adenocarcinoma
- Diagnostic Imaging
- Pancreatic Neoplasms
- Plectin